Ownership should sit with a cross functional leader who understands both clinical operations and technology, often the CMIO. That role is well placed to coordinate IT, pharmacy, compliance and prescriber needs because EPCS affects each of them. Supporting ownership should include IT leadership, the head of pharmacy, EMR analysts and compliance officers so accountability matches the programme's scope.
What Ownership Needs to Solve in EPCS
EPCS ownership is less about a single department “having” the system and more about deciding who can resolve clinical, technical, and compliance trade-offs without fragmenting accountability. The owner must understand how prescribing workflow, authentication, pharmacy operations, and regulatory obligations fit together, because failures in any one area can block adoption or create unsafe workarounds.
A cross-functional owner also prevents the common mistake of treating EPCS as either an IT project or a clinical policy project. The implementation touches prescriber experience, identity proofing, access design, auditability, and medication workflow, so ownership has to reflect the full operating model rather than just the software.
In practice, the most effective owner is usually the CMIO or an equivalent clinical-technology leader, because that role can arbitrate between clinician usability and control requirements while keeping the programme aligned to healthcare identity security concerns such as clinician access, shared workstations, and EPCS workflow.
Why the CMIO Usually Fits Best
The CMIO sits at the intersection of clinical credibility and technical oversight, which matters when EPCS decisions affect both prescriber behaviour and system design. That role can coordinate pharmacy, compliance, IT, and EMR teams without forcing each group to own a problem it cannot fully see.
What matters most is not title alone, but authority to make decisions across workflow, policy, and technology. If the owner cannot influence prescribing standards, access provisioning, exception handling, and go-live readiness, the programme will drift into committee management with no clear decision point.
A strong CMIO-led model usually includes IT leadership for delivery, the head of pharmacy for medication workflow and controlled-substance policy, EMR analysts for build and integration, and compliance officers for oversight. That distribution matches the control surface and reduces the risk that one function optimises its own requirements at the expense of the whole process.
How to Divide Accountability Without Losing Control
EPCS works best when the ownership model is explicit: one accountable leader, several operational owners, and a clear escalation path for exceptions. The accountable leader should own final decisions, while supporting functions own the parts they can validate, configure, or monitor.
The practical rule is simple: clinical leadership owns workflow legitimacy, technical teams own implementation integrity, pharmacy owns medication-process alignment, and compliance owns assurance. If any of those areas are left implicit, gaps appear in training, access reviews, audit readiness, or prescriber support.
For organisations that already run structured security or access governance, this is the point where programme ownership should also align to access control and identity review processes, not just application deployment. That is why guidance from NIST SP 800-53 Rev 5 Security and Privacy Controls is useful for mapping responsibilities around access, authentication, audit, and configuration control, while NIST SP 800-63 Digital Identity Guidelines helps anchor the authentication side of prescriber access.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5, NIST SP 800-63 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | EPCS hinges on authenticated prescriber access and controlled user sign-in. |
| AU-6 — Audit Record Review, Analysis, and Reporting | EPCS ownership includes auditability for prescribing and exception handling. | |
| AC-6 — Least Privilege | EPCS role design must limit who can sign, approve, or administer prescribing functions. | |
| Recommendation — Enforce IA-2 for prescriber authentication before EPCS signing or order entry. Review EPCS audit records regularly to detect anomalous prescribing or access patterns. Restrict EPCS privileges to the minimum roles needed for prescribing and support. | ||
| NIST SP 800-63 | N/A — Digital Identity Guidelines | Prescriber authentication strength is central to EPCS access and signing assurance. |
| Recommendation — Use phishing-resistant authenticators and appropriate assurance for prescriber access. | ||
| ISO/IEC 27001:2022 | A.5.15 — Access control | EPCS ownership must align access decisions across clinical and technical roles. |
| Recommendation — Define and enforce access rules for prescribers, pharmacy staff, and admins. | ||
| CIS Controls v8 | CIS-6 — Access Control Management | EPCS depends on managed access, role assignment, and periodic review. |
| Recommendation — Maintain role-based access reviews for all EPCS users and administrators. | ||
Practitioner Guidance
What to prioritise: Assign one accountable owner who can make trade-offs across clinical workflow, identity controls, and implementation timing. If ownership is split evenly, the first failure is usually delayed decisions, not a technical defect.
What to verify: Confirm who can approve policy, who can approve build changes, who can sign off training, and who owns exception handling for prescribers and pharmacy staff. If those four decision paths are not named, the programme is not truly owned.
What good looks like: The owner can answer operational questions quickly, surface risks early, and drive a release plan that works for prescribers, IT, pharmacy, and compliance at the same time. The best signal is that unresolved issues do not bounce between teams.
Practitioner takeaway: EPCS ownership should be broad enough to cover the full workflow, but narrow enough that one leader is accountable for the outcome, because shared responsibility without clear authority usually becomes unmanaged risk.
Related resources from NHI Mgmt Group
- Who should own access decisions when ITSM and IAM responsibilities overlap?
- Who should own the rules that govern provisioning and deprovisioning when HR and IAM responsibilities overlap?
- Who should own least privilege when IGA and security responsibilities overlap?
- Who should own NIST CSF governance when cybersecurity responsibilities span technical and executive teams?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 28, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
